Adeona Pharmaceuticals Inc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (44)

Latest Posts

About This Stock More About This Stock
Mizuho Says Synthetic Biologics IBS Treatment May Be 'Interesting' For Valeant
Article By: The Fly
Friday, June 29, 2018 3:13 PM EDT
Mizuho analyst Irina Koffler raised her price target for Valeant Pharmaceuticals.
In this article: VRX, SYN
Read
Synthetic Biologics & Proteon Therapeutics Stock Prices Soar 30% & 45%, Respectively, On News Of Designations From The FDA
Article By: Lorimer Wilson
Thursday, May 11, 2017 10:17 AM EDT
The FDA handed out new breakthrough therapy designations for a whole slate of biotech drugs in the clinic and investors are still cheer each announcement with a big spike in stock prices: PRTO stock went up 46% on Wednesday; SYN's is up 30% today.
In this article: PRTO, CRBP, SYN
Read
E Forecasts And Recoupling
Article By: Vivian Lewis
Wednesday, February 3, 2016 3:21 PM EDT
Yesterday's market closed barely dented by the renewed drop in the oil price, leading some experts to say this new linkage was now ended. The decoupling was ended in spades, with markets tumbling.
In this article: BP, TTM, FCAU, DGRLY, CZZ, SLB, CCJ, VE, TEVA, SYN, GSK, BSBR, BNS, LBTYA, VOD, PSHZF, NOK, VRX, PAH, EXG, ETW, PT, CVC, SAN
Read
E Synthetic Biologics Sinks 14% On Phase 2 Trial Failure For Relapsing-Remitting Multiple Sclerosis
Article By: Terry Chrisomalis
Wednesday, February 3, 2016 2:39 AM EDT
With these clinical findings, the company has chosen to abandon the Trimesta program and focus clinical resources on two gut microbiome programs.
In this article: SYN
Read
E Synthetic Biologics Announces Positive Phase 2 Results For Prevention Of Bacterial Infection
Article By: Terry Chrisomalis
Tuesday, December 1, 2015 8:30 PM EDT
Synthetic Biologics announces positive phase 2 results for prevention of bacterial infection
In this article: SYN
Read

PARTNER HEADLINES

Latest Tweets for $SYN

No tweets yet!